Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

  • Diabetes (898)
    • Blood Glucose Meters (9)
    • Complications (201)
    • Diabetes in Pregnancy (12)
    • Diabetes Meds (83)
    • Drug-Induced Hypo/Hyperglycemia (140)
    • Monitoring (139)
    • Natural Medicines/Supplements (9)
    • Prevention (47)
    • Treatment (371)
      • Alpha-Glucosidase Inhibitors (27)
      • Amylin Agonist (20)
      • Bromocriptine (10)
      • Combination Products (23)
      • Gliptins (85)
      • Glitazones (129)
      • GLP-1 (41)
      • Incretin Enhancers/Mimetics (82)
      • Insulin (197)
      • Meglitinides (46)
      • Metformin (165)
      • SGLT2 Inhibitors (86)
      • Sulfonylureas (131)
      • Treatment of Pediatric Metabolic Syndrome (10)
  • Endocrinology (9)
  • Hyperglycemia (39)
  • Hypoglycemia (19)
  • Other (31)
  • Prediabetes (5)
  • Resources (277)
  • Thyroid Disorders (63)
196 - 210 of 371 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
PL Voices: Toujeo (insulin glargine): First U-300 Basal Insulin April 2015
Article: Feel More Comfortable Dispensing Metformin in STABLE Kidney Disease March 2015
Article: Suggest Saving Afrezza for Patients Who Balk at Mealtime Insulin Injections March 2015
PL Voices: Role of the Inhaled Insulin, Afrezza, for Diabetes March 2015
Article: Use eGFR Instead of Cockcroft Gault for "Flozin" Dosing February 2015
Article: Suggest the Shortest and Thinnest Insulin Needle Available January 2015
Article: Consider GLP-1 Agonists...Including New Trulicity...as Metformin Add-Ons December 2014
Article: Remind Patients to Gently Mix "Cloudy" Insulins...Even in Pens December 2014
PL Voices: Role of SGLT2 Inhibitors for Type 2 Diabetes October 2014
Article: Advise Taking "Flozins" in the Morning October 2014
PL Voices: Comparing GLP-1 Agonists for Type 2 Diabetes August 2014
Article: Watch for Avandia Rxs...Again August 2014
Article: Consider a GLP-1 Agonist for Diabetic Patients on 2 or 3 Oral Meds August 2014
Article: Be Careful Where You Place Rx Labels On Insulin Products July 2014
Article: Discourage Using Sliding Scale Insulin Alone in Noncritical Patients July 2014
  • « Prev
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved